Are skeletal muscle FNDC5 gene expression and irisin release regulated by exercise and related to health?
Key points • Contradictory findings have been reported concerning the function of irisin and its precursor gene, skeletal muscle FNDC5, in energy homeostasis and metabolic health, and the associated regulatory role of exercise and PGC‐1α. • We analysed the effects of different short‐ and long‐term...
Saved in:
| Published in | The Journal of physiology Vol. 591; no. 21; pp. 5393 - 5400 |
|---|---|
| Main Authors | , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Oxford, UK
Blackwell Publishing Ltd
01.11.2013
Wiley Subscription Services, Inc Blackwell Science Inc |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0022-3751 1469-7793 1469-7793 |
| DOI | 10.1113/jphysiol.2013.263707 |
Cover
| Abstract | Key points
•
Contradictory findings have been reported concerning the function of irisin and its precursor gene, skeletal muscle FNDC5, in energy homeostasis and metabolic health, and the associated regulatory role of exercise and PGC‐1α.
•
We analysed the effects of different short‐ and long‐term exercise regimens on muscle FNDC5 and PGC‐1α, and serum irisin, and studied the associations of irisin and FNDC5 with health parameters.
•
FNDC5 and serum irisin did not change after acute aerobic, long‐term endurance training or endurance training combined with resistance exercise (RE) training, or associate with metabolic disturbances. A single RE bout increased FNDC5 mRNA in young, but not older men (27 vs. 62 years). Changes in PGC‐1α or serum irisin were not consistently accompanied by changes in FNDC5.
•
Our data suggest that the effects of exercise on FNDC5 and irisin are not consistent, and that their role in health is questionable. Moreover, the regulatory mechanisms should be studied further.
Recently, contradictory findings have been reported concerning the function of irisin and its precursor gene, skeletal muscle FNDC5, in energy homeostasis, and the associated regulatory role of exercise and PGC‐1α. We therefore evaluated whether muscle FNDC5 mRNA and serum irisin are exercise responsive and whether PGC‐1α expression is associated with FNDC5 expression. The male subjects in the study performed single exercises: (1) 1 h low‐intensity aerobic exercise (AE) (middle‐aged, n= 17), (2) a heavy‐intensity resistance exercise (RE) bout (young n= 10, older n= 11) (27 vs. 62 years), (3) long‐term 21 weeks endurance exercise (EE) training alone (twice a week, middle‐aged, n= 9), or (4) combined EE and RE training (both twice a week, middle‐aged, n= 9). Skeletal muscle mRNA expression was analysed by quantitative PCR and serum irisin by ELISA. No significant changes were observed in skeletal muscle PGC‐1α, FNDC5 and serum irisin after AE, EE training or combined EE + RE training. However, a single RE bout increased PGC‐1α by 4‐fold in young and by 2‐fold in older men, while FNDC5 mRNA only increased in young men post‐RE, by 1.4‐fold. Changes in PGC‐1α or serum irisin were not consistently accompanied by changes in FNDC5. In conclusion, for the most part, neither longer‐term nor single exercise markedly increases skeletal muscle FNDC5 expression or serum irisin. Therefore their changes in response to exercise are probably random and not consistent excluding the confirmation of any definitive link between exercise and FNDC5 expression and irisin release in humans. Moreover, irisin and FNDC5 were not associated with glucose tolerance and being overweight, or with metabolic disturbances, respectively. Finally, factor(s) other than PGC‐1α and transcription may regulate FNDC5 expression. |
|---|---|
| AbstractList | times Contradictory findings have been reported concerning the function of irisin and its precursor gene, skeletal muscle FNDC5, in energy homeostasis and metabolic health, and the associated regulatory role of exercise and PGC-1 alpha . Abstract Recently, contradictory findings have been reported concerning the function of irisin and its precursor gene, skeletal muscle FNDC5, in energy homeostasis, and the associated regulatory role of exercise and PGC-1 alpha . We therefore evaluated whether muscle FNDC5 mRNA and serum irisin are exercise responsive and whether PGC-1 alpha expression is associated with FNDC5 expression. The male subjects in the study performed single exercises: (1) 1 h low-intensity aerobic exercise (AE) (middle-aged, n= 17), (2) a heavy-intensity resistance exercise (RE) bout (young n= 10, older n= 11) (27 vs. 62 years), (3) long-term 21 weeks endurance exercise (EE) training alone (twice a week, middle-aged, n= 9), or (4) combined EE and RE training (both twice a week, middle-aged, n= 9). Skeletal muscle mRNA expression was analysed by quantitative PCR and serum irisin by ELISA. No significant changes were observed in skeletal muscle PGC-1 alpha , FNDC5 and serum irisin after AE, EE training or combined EE + RE training. However, a single RE bout increased PGC-1 alpha by 4-fold in young and by 2-fold in older men, while FNDC5 mRNA only increased in young men post-RE, by 1.4-fold. Changes in PGC-1 alpha or serum irisin were not consistently accompanied by changes in FNDC5. In conclusion, for the most part, neither longer-term nor single exercise markedly increases skeletal muscle FNDC5 expression or serum irisin. Therefore their changes in response to exercise are probably random and not consistent excluding the confirmation of any definitive link between exercise and FNDC5 expression and irisin release in humans. Moreover, irisin and FNDC5 were not associated with glucose tolerance and being overweight, or with metabolic disturbances, respectively. Finally, factor(s) other than PGC-1 alpha and transcription may regulate FNDC5 expression. Recently, contradictory findings have been reported concerning the function of irisin and its precursor gene, skeletal muscle FNDC5, in energy homeostasis, and the associated regulatory role of exercise and PGC-1α. We therefore evaluated whether muscle FNDC5 mRNA and serum irisin are exercise responsive and whether PGC-1α expression is associated with FNDC5 expression. The male subjects in the study performed single exercises: (1) 1 h low-intensity aerobic exercise (AE) (middle-aged, n = 17), (2) a heavy-intensity resistance exercise (RE) bout (young n = 10, older n = 11) (27 vs. 62 years), (3) long-term 21 weeks endurance exercise (EE) training alone (twice a week, middle-aged, n = 9), or (4) combined EE and RE training (both twice a week, middle-aged, n = 9). Skeletal muscle mRNA expression was analysed by quantitative PCR and serum irisin by ELISA. No significant changes were observed in skeletal muscle PGC-1α, FNDC5 and serum irisin after AE, EE training or combined EE + RE training. However, a single RE bout increased PGC-1α by 4-fold in young and by 2-fold in older men, while FNDC5 mRNA only increased in young men post-RE, by 1.4-fold. Changes in PGC-1α or serum irisin were not consistently accompanied by changes in FNDC5. In conclusion, for the most part, neither longer-term nor single exercise markedly increases skeletal muscle FNDC5 expression or serum irisin. Therefore their changes in response to exercise are probably random and not consistent excluding the confirmation of any definitive link between exercise and FNDC5 expression and irisin release in humans. Moreover, irisin and FNDC5 were not associated with glucose tolerance and being overweight, or with metabolic disturbances, respectively. Finally, factor(s) other than PGC-1α and transcription may regulate FNDC5 expression. Key points * Contradictory findings have been reported concerning the function of irisin and its precursor gene, skeletal muscle FNDC5, in energy homeostasis and metabolic health, and the associated regulatory role of exercise and PGC-1[alpha]. * We analysed the effects of different short- and long-term exercise regimens on muscle FNDC5 and PGC-1[alpha], and serum irisin, and studied the associations of irisin and FNDC5 with health parameters. * FNDC5 and serum irisin did not change after acute aerobic, long-term endurance training or endurance training combined with resistance exercise (RE) training, or associate with metabolic disturbances. A single RE bout increased FNDC5 mRNA in young, but not older men (27 vs. 62 years). Changes in PGC-1[alpha] or serum irisin were not consistently accompanied by changes in FNDC5. * Our data suggest that the effects of exercise on FNDC5 and irisin are not consistent, and that their role in health is questionable. Moreover, the regulatory mechanisms should be studied further. Abstract Recently, contradictory findings have been reported concerning the function of irisin and its precursor gene, skeletal muscle FNDC5, in energy homeostasis, and the associated regulatory role of exercise and PGC-1[alpha]. We therefore evaluated whether muscle FNDC5 mRNA and serum irisin are exercise responsive and whether PGC-1[alpha] expression is associated with FNDC5 expression. The male subjects in the study performed single exercises: (1) 1 h low-intensity aerobic exercise (AE) (middle-aged, n= 17), (2) a heavy-intensity resistance exercise (RE) bout (young n= 10, older n= 11) (27 vs. 62 years), (3) long-term 21 weeks endurance exercise (EE) training alone (twice a week, middle-aged, n= 9), or (4) combined EE and RE training (both twice a week, middle-aged, n= 9). Skeletal muscle mRNA expression was analysed by quantitative PCR and serum irisin by ELISA. No significant changes were observed in skeletal muscle PGC-1[alpha], FNDC5 and serum irisin after AE, EE training or combined EE + RE training. However, a single RE bout increased PGC-1[alpha] by 4-fold in young and by 2-fold in older men, while FNDC5 mRNA only increased in young men post-RE, by 1.4-fold. Changes in PGC-1[alpha] or serum irisin were not consistently accompanied by changes in FNDC5. In conclusion, for the most part, neither longer-term nor single exercise markedly increases skeletal muscle FNDC5 expression or serum irisin. Therefore their changes in response to exercise are probably random and not consistent excluding the confirmation of any definitive link between exercise and FNDC5 expression and irisin release in humans. Moreover, irisin and FNDC5 were not associated with glucose tolerance and being overweight, or with metabolic disturbances, respectively. Finally, factor(s) other than PGC-1[alpha] and transcription may regulate FNDC5 expression. Recently, contradictory findings have been reported concerning the function of irisin and its precursor gene, skeletal muscle FNDC5 , in energy homeostasis, and the associated regulatory role of exercise and PGC-1α . We therefore evaluated whether muscle FNDC5 mRNA and serum irisin are exercise responsive and whether PGC-1α expression is associated with FNDC5 expression. The male subjects in the study performed single exercises: (1) 1 h low-intensity aerobic exercise (AE) (middle-aged, n = 17), (2) a heavy-intensity resistance exercise (RE) bout (young n = 10, older n = 11) (27 vs. 62 years), (3) long-term 21 weeks endurance exercise (EE) training alone (twice a week, middle-aged, n = 9), or (4) combined EE and RE training (both twice a week, middle-aged, n = 9). Skeletal muscle mRNA expression was analysed by quantitative PCR and serum irisin by ELISA. No significant changes were observed in skeletal muscle PGC-1α , FNDC5 and serum irisin after AE, EE training or combined EE + RE training. However, a single RE bout increased PGC-1α by 4-fold in young and by 2-fold in older men, while FNDC5 mRNA only increased in young men post-RE, by 1.4-fold. Changes in PGC-1α or serum irisin were not consistently accompanied by changes in FNDC5 . In conclusion, for the most part, neither longer-term nor single exercise markedly increases skeletal muscle FNDC5 expression or serum irisin. Therefore their changes in response to exercise are probably random and not consistent excluding the confirmation of any definitive link between exercise and FNDC5 expression and irisin release in humans. Moreover, irisin and FNDC5 were not associated with glucose tolerance and being overweight, or with metabolic disturbances, respectively. Finally, factor(s) other than PGC-1α and transcription may regulate FNDC5 expression. Key points • Contradictory findings have been reported concerning the function of irisin and its precursor gene, skeletal muscle FNDC5, in energy homeostasis and metabolic health, and the associated regulatory role of exercise and PGC‐1α. • We analysed the effects of different short‐ and long‐term exercise regimens on muscle FNDC5 and PGC‐1α, and serum irisin, and studied the associations of irisin and FNDC5 with health parameters. • FNDC5 and serum irisin did not change after acute aerobic, long‐term endurance training or endurance training combined with resistance exercise (RE) training, or associate with metabolic disturbances. A single RE bout increased FNDC5 mRNA in young, but not older men (27 vs. 62 years). Changes in PGC‐1α or serum irisin were not consistently accompanied by changes in FNDC5. • Our data suggest that the effects of exercise on FNDC5 and irisin are not consistent, and that their role in health is questionable. Moreover, the regulatory mechanisms should be studied further. Recently, contradictory findings have been reported concerning the function of irisin and its precursor gene, skeletal muscle FNDC5, in energy homeostasis, and the associated regulatory role of exercise and PGC‐1α. We therefore evaluated whether muscle FNDC5 mRNA and serum irisin are exercise responsive and whether PGC‐1α expression is associated with FNDC5 expression. The male subjects in the study performed single exercises: (1) 1 h low‐intensity aerobic exercise (AE) (middle‐aged, n= 17), (2) a heavy‐intensity resistance exercise (RE) bout (young n= 10, older n= 11) (27 vs. 62 years), (3) long‐term 21 weeks endurance exercise (EE) training alone (twice a week, middle‐aged, n= 9), or (4) combined EE and RE training (both twice a week, middle‐aged, n= 9). Skeletal muscle mRNA expression was analysed by quantitative PCR and serum irisin by ELISA. No significant changes were observed in skeletal muscle PGC‐1α, FNDC5 and serum irisin after AE, EE training or combined EE + RE training. However, a single RE bout increased PGC‐1α by 4‐fold in young and by 2‐fold in older men, while FNDC5 mRNA only increased in young men post‐RE, by 1.4‐fold. Changes in PGC‐1α or serum irisin were not consistently accompanied by changes in FNDC5. In conclusion, for the most part, neither longer‐term nor single exercise markedly increases skeletal muscle FNDC5 expression or serum irisin. Therefore their changes in response to exercise are probably random and not consistent excluding the confirmation of any definitive link between exercise and FNDC5 expression and irisin release in humans. Moreover, irisin and FNDC5 were not associated with glucose tolerance and being overweight, or with metabolic disturbances, respectively. Finally, factor(s) other than PGC‐1α and transcription may regulate FNDC5 expression. Contradictory findings have been reported concerning the function of irisin and its precursor gene, skeletal muscle FNDC5 , in energy homeostasis and metabolic health, and the associated regulatory role of exercise and PGC‐1α . We analysed the effects of different short‐ and long‐term exercise regimens on muscle FNDC5 and PGC‐1α , and serum irisin, and studied the associations of irisin and FNDC5 with health parameters. FNDC5 and serum irisin did not change after acute aerobic, long‐term endurance training or endurance training combined with resistance exercise (RE) training, or associate with metabolic disturbances. A single RE bout increased FNDC5 mRNA in young, but not older men (27 vs. 62 years). Changes in PGC‐1α or serum irisin were not consistently accompanied by changes in FNDC5 . Our data suggest that the effects of exercise on FNDC5 and irisin are not consistent, and that their role in health is questionable. Moreover, the regulatory mechanisms should be studied further. Abstract Recently, contradictory findings have been reported concerning the function of irisin and its precursor gene, skeletal muscle FNDC5 , in energy homeostasis, and the associated regulatory role of exercise and PGC‐1α . We therefore evaluated whether muscle FNDC5 mRNA and serum irisin are exercise responsive and whether PGC‐1α expression is associated with FNDC5 expression. The male subjects in the study performed single exercises: (1) 1 h low‐intensity aerobic exercise (AE) (middle‐aged, n = 17), (2) a heavy‐intensity resistance exercise (RE) bout (young n = 10, older n = 11) (27 vs. 62 years), (3) long‐term 21 weeks endurance exercise (EE) training alone (twice a week, middle‐aged, n = 9), or (4) combined EE and RE training (both twice a week, middle‐aged, n = 9). Skeletal muscle mRNA expression was analysed by quantitative PCR and serum irisin by ELISA. No significant changes were observed in skeletal muscle PGC‐1α , FNDC5 and serum irisin after AE, EE training or combined EE + RE training. However, a single RE bout increased PGC‐1α by 4‐fold in young and by 2‐fold in older men, while FNDC5 mRNA only increased in young men post‐RE, by 1.4‐fold. Changes in PGC‐1α or serum irisin were not consistently accompanied by changes in FNDC5 . In conclusion, for the most part, neither longer‐term nor single exercise markedly increases skeletal muscle FNDC5 expression or serum irisin. Therefore their changes in response to exercise are probably random and not consistent excluding the confirmation of any definitive link between exercise and FNDC5 expression and irisin release in humans. Moreover, irisin and FNDC5 were not associated with glucose tolerance and being overweight, or with metabolic disturbances, respectively. Finally, factor(s) other than PGC‐1α and transcription may regulate FNDC5 expression. Recently, contradictory findings have been reported concerning the function of irisin and its precursor gene, skeletal muscle FNDC5, in energy homeostasis, and the associated regulatory role of exercise and PGC-1α. We therefore evaluated whether muscle FNDC5 mRNA and serum irisin are exercise responsive and whether PGC-1α expression is associated with FNDC5 expression. The male subjects in the study performed single exercises: (1) 1 h low-intensity aerobic exercise (AE) (middle-aged, n = 17), (2) a heavy-intensity resistance exercise (RE) bout (young n = 10, older n = 11) (27 vs. 62 years), (3) long-term 21 weeks endurance exercise (EE) training alone (twice a week, middle-aged, n = 9), or (4) combined EE and RE training (both twice a week, middle-aged, n = 9). Skeletal muscle mRNA expression was analysed by quantitative PCR and serum irisin by ELISA. No significant changes were observed in skeletal muscle PGC-1α, FNDC5 and serum irisin after AE, EE training or combined EE + RE training. However, a single RE bout increased PGC-1α by 4-fold in young and by 2-fold in older men, while FNDC5 mRNA only increased in young men post-RE, by 1.4-fold. Changes in PGC-1α or serum irisin were not consistently accompanied by changes in FNDC5. In conclusion, for the most part, neither longer-term nor single exercise markedly increases skeletal muscle FNDC5 expression or serum irisin. Therefore their changes in response to exercise are probably random and not consistent excluding the confirmation of any definitive link between exercise and FNDC5 expression and irisin release in humans. Moreover, irisin and FNDC5 were not associated with glucose tolerance and being overweight, or with metabolic disturbances, respectively. Finally, factor(s) other than PGC-1α and transcription may regulate FNDC5 expression.Recently, contradictory findings have been reported concerning the function of irisin and its precursor gene, skeletal muscle FNDC5, in energy homeostasis, and the associated regulatory role of exercise and PGC-1α. We therefore evaluated whether muscle FNDC5 mRNA and serum irisin are exercise responsive and whether PGC-1α expression is associated with FNDC5 expression. The male subjects in the study performed single exercises: (1) 1 h low-intensity aerobic exercise (AE) (middle-aged, n = 17), (2) a heavy-intensity resistance exercise (RE) bout (young n = 10, older n = 11) (27 vs. 62 years), (3) long-term 21 weeks endurance exercise (EE) training alone (twice a week, middle-aged, n = 9), or (4) combined EE and RE training (both twice a week, middle-aged, n = 9). Skeletal muscle mRNA expression was analysed by quantitative PCR and serum irisin by ELISA. No significant changes were observed in skeletal muscle PGC-1α, FNDC5 and serum irisin after AE, EE training or combined EE + RE training. However, a single RE bout increased PGC-1α by 4-fold in young and by 2-fold in older men, while FNDC5 mRNA only increased in young men post-RE, by 1.4-fold. Changes in PGC-1α or serum irisin were not consistently accompanied by changes in FNDC5. In conclusion, for the most part, neither longer-term nor single exercise markedly increases skeletal muscle FNDC5 expression or serum irisin. Therefore their changes in response to exercise are probably random and not consistent excluding the confirmation of any definitive link between exercise and FNDC5 expression and irisin release in humans. Moreover, irisin and FNDC5 were not associated with glucose tolerance and being overweight, or with metabolic disturbances, respectively. Finally, factor(s) other than PGC-1α and transcription may regulate FNDC5 expression. |
| Author | Horttanainen, Mia Hulmi, Juha J. Kainulainen, Heikki Häkkinen, Keijo Herzig, Karl‐Heinz Wiklund, Petri K. Cheng, Sulin Nyman, Kai Ahtiainen, Juha P. Alén, Markku Pöllänen, Eija Pekkala, Satu Mäkelä, Kari A. |
| Author_xml | – sequence: 1 givenname: Satu surname: Pekkala fullname: Pekkala, Satu – sequence: 2 givenname: Petri K. surname: Wiklund fullname: Wiklund, Petri K. – sequence: 3 givenname: Juha J. surname: Hulmi fullname: Hulmi, Juha J. – sequence: 4 givenname: Juha P. surname: Ahtiainen fullname: Ahtiainen, Juha P. – sequence: 5 givenname: Mia surname: Horttanainen fullname: Horttanainen, Mia – sequence: 6 givenname: Eija surname: Pöllänen fullname: Pöllänen, Eija – sequence: 7 givenname: Kari A. surname: Mäkelä fullname: Mäkelä, Kari A. – sequence: 8 givenname: Heikki surname: Kainulainen fullname: Kainulainen, Heikki – sequence: 9 givenname: Keijo surname: Häkkinen fullname: Häkkinen, Keijo – sequence: 10 givenname: Kai surname: Nyman fullname: Nyman, Kai – sequence: 11 givenname: Markku surname: Alén fullname: Alén, Markku – sequence: 12 givenname: Karl‐Heinz surname: Herzig fullname: Herzig, Karl‐Heinz – sequence: 13 givenname: Sulin surname: Cheng fullname: Cheng, Sulin |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24000180$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkk1vEzEQhi1URNPAP0DIEhcuG_yxttccQFVK-VAFHMrZsjeziYPjTe1daP49Dmkr6IWeRh4_7zujmTlBR7GPgNBzSmaUUv56vV3tsu_DjBHKZ0xyRdQjNKG11JVSmh-hCSGMVVwJeoxOcl6TAhKtn6BjVpPyaMgE-dMEOP-AAIMNeDPmNgA-_3I2F3gJETBcbxPkUidiGxfYJ599xKnwNkOJyzHYARbY7QoKqfUluwcL8Sc_9HgFNgyrd0_R486GDM9u4hR9P39_Of9YXXz98Gl-elG1ohG00lIJp6iVlDrFlHS0FtAQRSTlHetAMaqdlC1XwB2DzjVOy1oslFOa2c7xKXp78N2ObgOLFuKQbDDb5Dc27Uxvvfn3J_qVWfY_Dde8DFEUg1c3Bqm_GiEPZuNzCyHYCP2YTZlww0Ujm_oBaK2Z4qIYT9HLe-i6H1Msk9hTimqlNSvUi7-bv-v6dmEFqA9Am_qcE3R3CCVmfxfm9i7M_i7M4S6K7M09WesHO5S1lhH48D-xPoh_-QC7BxU0l5-_iUZT_huCPNKL |
| CODEN | JPHYA7 |
| CitedBy_id | crossref_primary_10_1002_trc2_70056 crossref_primary_10_3389_fendo_2023_1326851 crossref_primary_10_2174_1871529X19666190918144727 crossref_primary_10_1016_j_exger_2015_07_006 crossref_primary_10_1016_j_ijbiomac_2021_02_181 crossref_primary_10_1515_cclm_2017_0674 crossref_primary_10_1155_2021_6572342 crossref_primary_10_3390_ijms22179623 crossref_primary_10_1111_ahe_12371 crossref_primary_10_1371_journal_pone_0120354 crossref_primary_10_58208_cphs_1195891 crossref_primary_10_1016_j_appet_2015_03_003 crossref_primary_10_2174_1874467214666210521170339 crossref_primary_10_4103_epj_epj_50_20 crossref_primary_10_1016_j_metabol_2013_11_009 crossref_primary_10_3389_fendo_2019_00621 crossref_primary_10_1016_j_cellsig_2020_109805 crossref_primary_10_1016_j_tips_2015_08_014 crossref_primary_10_1016_j_mce_2015_05_036 crossref_primary_10_1111_apha_12274 crossref_primary_10_1016_j_arteri_2013_11_002 crossref_primary_10_1016_j_metabol_2015_06_005 crossref_primary_10_1016_j_metabol_2014_01_005 crossref_primary_10_3390_jcm12010062 crossref_primary_10_3390_ijms22041530 crossref_primary_10_3109_07853890_2014_911595 crossref_primary_10_3390_ijms251810116 crossref_primary_10_1152_ajpendo_00034_2020 crossref_primary_10_1186_s12890_024_03412_z crossref_primary_10_1016_j_peptides_2018_03_018 crossref_primary_10_1096_fj_14_263699 crossref_primary_10_3390_biology11030392 crossref_primary_10_1186_s40200_016_0239_5 crossref_primary_10_1042_BCJ20170241 crossref_primary_10_4196_kjpp_2014_18_5_441 crossref_primary_10_1080_10520295_2017_1303194 crossref_primary_10_3389_fphys_2019_00042 crossref_primary_10_1530_EJE_15_1217 crossref_primary_10_1016_j_metabol_2014_04_001 crossref_primary_10_3109_07853890_2014_919727 crossref_primary_10_1007_s11914_020_00599_y crossref_primary_10_5507_ag_2018_007 crossref_primary_10_5812_asjsm_35205 crossref_primary_10_1371_journal_pone_0146605 crossref_primary_10_1136_bjsports_2016_096513 crossref_primary_10_1016_j_currproblcancer_2019_100529 crossref_primary_10_1186_s12986_018_0298_3 crossref_primary_10_1038_srep43296 crossref_primary_10_1016_j_peptides_2014_03_003 crossref_primary_10_25048_tudod_1516025 crossref_primary_10_1080_17461391_2018_1478452 crossref_primary_10_1016_j_metabol_2015_09_001 crossref_primary_10_1074_jbc_M113_516641 crossref_primary_10_1007_s00210_022_02211_9 crossref_primary_10_1186_s12890_015_0035_x crossref_primary_10_2147_CIA_S308893 crossref_primary_10_1002_rco2_70000 crossref_primary_10_1093_jmcb_mjab038 crossref_primary_10_1096_fj_202301619R crossref_primary_10_1007_s12020_015_0607_9 crossref_primary_10_1007_s40519_018_0491_4 crossref_primary_10_1186_s12885_015_1898_1 crossref_primary_10_23736_S2724_6507_20_03361_1 crossref_primary_10_3390_ani10122268 crossref_primary_10_51847_CX5VHf76Yw crossref_primary_10_1007_s40618_021_01529_0 crossref_primary_10_51539_biotech_1180314 crossref_primary_10_1530_JOE_14_0189 crossref_primary_10_1016_j_metabol_2016_02_006 crossref_primary_10_24171_j_phrp_2023_0394 crossref_primary_10_33549_physiolres_934896 crossref_primary_10_3389_fendo_2019_00549 crossref_primary_10_7717_peerj_18413 crossref_primary_10_3109_09513590_2014_920006 crossref_primary_10_3389_fphys_2020_00923 crossref_primary_10_3390_jcm14030793 crossref_primary_10_1016_j_gene_2018_09_024 crossref_primary_10_1155_2018_7816806 crossref_primary_10_3390_medicina56060274 crossref_primary_10_1152_ajpendo_00308_2013 crossref_primary_10_1016_j_gene_2020_145018 crossref_primary_10_1016_j_pcad_2019_02_007 crossref_primary_10_1007_s13679_014_0091_1 crossref_primary_10_3390_ijerph17103589 crossref_primary_10_3390_foods10102318 crossref_primary_10_1007_s12262_024_04257_w crossref_primary_10_1080_17461391_2018_1506504 crossref_primary_10_1007_s00424_018_2177_1 crossref_primary_10_1186_s11556_022_00303_2 crossref_primary_10_1530_JOE_16_0211 crossref_primary_10_1155_2017_1039161 crossref_primary_10_1016_j_yfrne_2022_100993 crossref_primary_10_1016_j_metabol_2013_12_007 crossref_primary_10_1113_jphysiol_2013_265371 crossref_primary_10_3389_fendo_2019_00524 crossref_primary_10_1155_2015_359159 crossref_primary_10_1590_1678_4685_jbn_3802 crossref_primary_10_29252_jarums_18_1_80 crossref_primary_10_3390_ijms26010350 crossref_primary_10_1016_j_conctc_2025_101464 crossref_primary_10_3390_jcm8050653 crossref_primary_10_31083_j_rcm2305160 crossref_primary_10_5812_asjsm_68943 crossref_primary_10_29252_aassjournal_6_1_21 crossref_primary_10_3390_healthcare9111438 crossref_primary_10_1016_j_exger_2021_111648 crossref_primary_10_1515_labmed_2017_0042 crossref_primary_10_15857_ksep_2017_26_1_17 crossref_primary_10_5812_asjsm_13025 crossref_primary_10_1080_13813455_2020_1849310 crossref_primary_10_3389_fphys_2018_01307 crossref_primary_10_1111_eci_12468 crossref_primary_10_1111_febs_12619 crossref_primary_10_1371_journal_pone_0170690 crossref_primary_10_1016_j_bbrc_2019_08_112 crossref_primary_10_20463_jenb_2018_0011 crossref_primary_10_1016_j_arr_2022_101680 crossref_primary_10_61186_jspac_36659_2_4_3 crossref_primary_10_18229_kocatepetip_1138553 crossref_primary_10_15857_ksep_2023_00374 crossref_primary_10_4103_abr_abr_220_20 crossref_primary_10_1016_j_metabol_2015_05_010 crossref_primary_10_1186_s13098_017_0302_5 crossref_primary_10_1152_physiol_00067_2013 crossref_primary_10_2147_DMSO_S391219 crossref_primary_10_1530_EJE_14_0204 crossref_primary_10_1556_2060_2020_00037 crossref_primary_10_1111_sms_12904 crossref_primary_10_1080_13813455_2019_1673432 crossref_primary_10_1111_apha_12421 crossref_primary_10_14814_phy2_12343 crossref_primary_10_1007_s11332_023_01152_x crossref_primary_10_1016_j_obmed_2015_12_002 crossref_primary_10_1016_j_tem_2022_06_003 crossref_primary_10_1111_cen_12672 crossref_primary_10_1371_journal_pone_0090696 crossref_primary_10_1177_10998004221142580 crossref_primary_10_1038_srep08889 crossref_primary_10_1155_2015_620919 crossref_primary_10_3390_cells11010160 crossref_primary_10_17795_ajmb_33230 crossref_primary_10_18585_inabj_v6i2_32 crossref_primary_10_1016_j_cell_2018_10_025 crossref_primary_10_1139_apnm_2020_1087 crossref_primary_10_1016_j_metabol_2015_12_006 crossref_primary_10_1016_j_peptides_2014_01_016 crossref_primary_10_3390_ijerph18116042 crossref_primary_10_1038_ijo_2015_130 crossref_primary_10_31189_2165_6193_12_4_111 crossref_primary_10_56984_8ZG01A8Q3S7 crossref_primary_10_1002_dmrr_2660 crossref_primary_10_1016_j_metabol_2015_01_001 crossref_primary_10_1007_s11357_014_9733_1 crossref_primary_10_1016_j_imr_2018_01_007 crossref_primary_10_2147_CIA_S482479 crossref_primary_10_2478_enr_2024_0013 crossref_primary_10_3390_jcm12154881 crossref_primary_10_3389_fnagi_2022_934406 crossref_primary_10_3389_fphys_2020_562895 crossref_primary_10_1146_annurev_physiol_021115_105305 crossref_primary_10_1016_j_jshs_2017_01_003 crossref_primary_10_1265_ehpm_23_00146 crossref_primary_10_1016_j_jesf_2020_06_004 crossref_primary_10_1111_apha_13785 crossref_primary_10_3390_ijms23105723 crossref_primary_10_1016_j_scispo_2022_08_004 crossref_primary_10_1007_s12020_016_0913_x crossref_primary_10_12688_f1000research_11107_2 crossref_primary_10_3390_biology11070999 crossref_primary_10_12688_f1000research_11107_1 crossref_primary_10_1038_nrendo_2016_221 crossref_primary_10_3390_jcdd9090305 crossref_primary_10_33549_physiolres_932997 crossref_primary_10_1113_EP086049 crossref_primary_10_1007_s00125_014_3224_x crossref_primary_10_1016_j_scispo_2016_07_005 crossref_primary_10_1371_journal_pone_0088060 crossref_primary_10_1016_j_neuroscience_2020_03_042 crossref_primary_10_1080_10520295_2016_1183820 crossref_primary_10_3390_ijms20246159 crossref_primary_10_1007_s00421_015_3116_x crossref_primary_10_1186_s13098_022_00922_w crossref_primary_10_1007_s40279_014_0293_4 crossref_primary_10_7717_peerj_17958 crossref_primary_10_1007_s12291_022_01083_3 crossref_primary_10_15561_20755279_2018_0604 crossref_primary_10_1074_jbc_M114_591008 crossref_primary_10_1016_j_bbr_2021_113472 crossref_primary_10_58962_HSR_2024_10_1_27_38 crossref_primary_10_1007_s12576_018_0619_3 crossref_primary_10_1007_s12020_018_1814_y crossref_primary_10_1016_j_jshs_2024_04_005 crossref_primary_10_3390_nu12030742 crossref_primary_10_1210_jc_2014_1367 crossref_primary_10_3390_metabo11020111 crossref_primary_10_4093_dmj_2016_40_5_386 crossref_primary_10_1139_apnm_2017_0614 crossref_primary_10_1155_2022_8235809 crossref_primary_10_2147_DMSO_S249090 crossref_primary_10_3390_antiox10020240 crossref_primary_10_1038_s41574_019_0174_x crossref_primary_10_3920_CEP210031 crossref_primary_10_1016_j_peptides_2014_07_021 crossref_primary_10_3390_ijms23073501 crossref_primary_10_1016_j_scispo_2017_11_002 crossref_primary_10_1111_ahe_12345 crossref_primary_10_3109_07853890_2014_952328 crossref_primary_10_3389_fcvm_2023_1074061 crossref_primary_10_3390_nu16234231 |
| Cites_doi | 10.1055/s-0029-1238290 10.1007/s00421-007-0579-4 10.1371/journal.pone.0060563 10.1038/nature10777 10.1111/j.1600-0838.2009.01059.x 10.1007/s10059-010-0159-z 10.1210/jc.2012-2749 10.1038/nature11364 10.1152/japplphysiol.00087.2009 10.1016/j.metabol.2013.02.002 10.1016/j.febslet.2007.11.034 10.1038/nature03354 10.1152/ajprenal.90340.2008 10.1007/s00726-008-0150-6 10.1016/j.metabol.2012.09.002 10.1186/1743-7075-9-90 |
| ContentType | Journal Article |
| Copyright | 2013 The Authors. The Journal of Physiology © 2013 The Physiological Society 2013 The Authors. The Journal of Physiology © 2013 The Physiological Society 2013 |
| Copyright_xml | – notice: 2013 The Authors. The Journal of Physiology © 2013 The Physiological Society – notice: 2013 The Authors. The Journal of Physiology © 2013 The Physiological Society 2013 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QP 7QR 7TK 7TS 8FD FR3 P64 7X8 RC3 5PM |
| DOI | 10.1113/jphysiol.2013.263707 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Neurosciences Abstracts Physical Education Index Technology Research Database Engineering Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic Genetics Abstracts PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Technology Research Database Chemoreception Abstracts Engineering Research Database Calcium & Calcified Tissue Abstracts Neurosciences Abstracts Physical Education Index Biotechnology and BioEngineering Abstracts MEDLINE - Academic Genetics Abstracts |
| DatabaseTitleList | Genetics Abstracts MEDLINE Technology Research Database CrossRef MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Anatomy & Physiology |
| EISSN | 1469-7793 |
| EndPage | 5400 |
| ExternalDocumentID | PMC3936375 3113596211 24000180 10_1113_jphysiol_2013_263707 TJP5891 |
| Genre | rapidPublication Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | --- -DZ -~X .3N .55 .GA .GJ .Y3 05W 0R~ 0YM 10A 123 18M 1OC 29L 2WC 31~ 33P 36B 3EH 3O- 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAFWJ AAHQN AAIPD AAMNL AANLZ AAONW AASGY AAXRX AAYCA AAYJJ AAZKR ABCQN ABCUV ABEML ABITZ ABIVO ABJNI ABOCM ABPPZ ABPVW ABQWH ABXGK ACAHQ ACCZN ACFBH ACGFO ACGFS ACGOF ACIWK ACMXC ACNCT ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADXHL ADZMN AEGXH AEIGN AEIMD AEUYR AEYWJ AFBPY AFEBI AFFNX AFFPM AFGKR AFWVQ AFZJQ AGHNM AGYGG AHBTC AI. AIACR AIAGR AITYG AIURR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB AOIJS ATUGU AZBYB AZVAB BAFTC BAWUL BFHJK BHBCM BMXJE BROTX BRXPI BY8 C1A C45 CAG CHEAL COF CS3 D-6 D-7 D-E D-F DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM E3Z EBS EJD EMOBN EX3 F00 F01 F04 F5P FA8 FIJ FUBAC G-S G.N GODZA GX1 H.X H13 HF~ HGLYW HZI HZ~ H~9 IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MVM MXFUL MXMAN MXSTM N04 N05 N9A NEJ NF~ O66 O9- OHT OIG OK1 OVD P2P P2W P2X P2Z P4B P4D Q.N Q11 QB0 R.K ROL RPM RX1 SUPJJ TEORI TLM TN5 TR2 UB1 UKR UPT V8K VH1 W8F W8V W99 WBKPD WH7 WHG WIH WIJ WIK WIN WNSPC WOHZO WOQ WOW WQJ WXI WXSBR WYISQ X7M XG1 XOL YBU YHG YKV YQT YSK YXB YYP YZZ ZGI ZXP ZZTAW ~IA ~WT AAHHS AAYXX ACCFJ AEEZP AEQDE AIWBW AJBDE CITATION RIG CGR CUY CVF ECM EIF NPM 7QP 7QR 7TK 7TS 8FD FR3 P64 7X8 RC3 5PM |
| ID | FETCH-LOGICAL-c5851-9675b71a611b7276b145e8070613f2fe7219b66c37e3b2efb8b9645d7b792afb3 |
| IEDL.DBID | DR2 |
| ISSN | 0022-3751 1469-7793 |
| IngestDate | Thu Aug 21 14:10:42 EDT 2025 Fri Jul 11 12:00:06 EDT 2025 Fri Jul 11 15:26:26 EDT 2025 Fri Jul 25 12:11:46 EDT 2025 Thu Apr 03 06:52:50 EDT 2025 Tue Jul 01 04:29:10 EDT 2025 Thu Apr 24 22:57:18 EDT 2025 Wed Aug 20 07:24:41 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 21 |
| Language | English |
| License | http://onlinelibrary.wiley.com/termsAndConditions#vor |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c5851-9675b71a611b7276b145e8070613f2fe7219b66c37e3b2efb8b9645d7b792afb3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1113/jphysiol.2013.263707 |
| PMID | 24000180 |
| PQID | 1447197992 |
| PQPubID | 1086388 |
| PageCount | 8 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3936375 proquest_miscellaneous_1468358684 proquest_miscellaneous_1449273536 proquest_journals_1447197992 pubmed_primary_24000180 crossref_primary_10_1113_jphysiol_2013_263707 crossref_citationtrail_10_1113_jphysiol_2013_263707 wiley_primary_10_1113_jphysiol_2013_263707_TJP5891 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | November 2013 |
| PublicationDateYYYYMMDD | 2013-11-01 |
| PublicationDate_xml | – month: 11 year: 2013 text: November 2013 |
| PublicationDecade | 2010 |
| PublicationPlace | Oxford, UK |
| PublicationPlace_xml | – name: Oxford, UK – name: England – name: London |
| PublicationTitle | The Journal of physiology |
| PublicationTitleAlternate | J Physiol |
| PublicationYear | 2013 |
| Publisher | Blackwell Publishing Ltd Wiley Subscription Services, Inc Blackwell Science Inc |
| Publisher_xml | – name: Blackwell Publishing Ltd – name: Wiley Subscription Services, Inc – name: Blackwell Science Inc |
| References | 2012; 61 2012; 481 2010; 21 2009; 30 2009b; 106 2013; 98 2013; 62 2005; 434 2009a; 37 2008; 102 2009; 296 2012; 488 2013; 8 2008; 582 2010; 30 2012; 9 e_1_2_6_10_1 e_1_2_6_9_1 e_1_2_6_8_1 e_1_2_6_5_1 e_1_2_6_4_1 e_1_2_6_7_1 e_1_2_6_6_1 e_1_2_6_13_1 e_1_2_6_14_1 e_1_2_6_3_1 e_1_2_6_11_1 e_1_2_6_2_1 e_1_2_6_12_1 e_1_2_6_17_1 e_1_2_6_15_1 e_1_2_6_16_1 23593248 - PLoS One. 2013;8(4):e60563 18661258 - Amino Acids. 2009 Jul;37(2):297-308 23436919 - J Clin Endocrinol Metab. 2013 Apr;98(4):E769-78 23018146 - Metabolism. 2012 Dec;61(12):1725-38 18971212 - Am J Physiol Renal Physiol. 2009 Mar;296(3):F459-69 22237023 - Nature. 2012 Jan 26;481(7382):463-8 15744310 - Nature. 2005 Mar 3;434(7029):113-8 19885781 - Int J Sports Med. 2009 Dec;30(12):879-87 23498898 - Metabolism. 2013 Aug;62(8):1052-6 21340671 - Mol Cells. 2010 Dec;30(6):497-506 23067400 - Nutr Metab (Lond). 2012 Oct 15;9(1):90 22932392 - Nature. 2012 Aug 30;488(7413):E9-10; discussion E10-1 19299575 - J Appl Physiol (1985). 2009 May;106(5):1720-9 18036349 - FEBS Lett. 2008 Jan 9;582(1):46-53 24187077 - J Physiol. 2013 Nov 1;591(21):5267-8 17924133 - Eur J Appl Physiol. 2008 Jan;102(2):205-13 20030775 - Scand J Med Sci Sports. 2011 Jun;21(3):402-11 |
| References_xml | – volume: 8 start-page: e60563 year: 2013 article-title: FNDC5/irisin is not only a myokine but also an adipokine publication-title: PLoS One – volume: 582 start-page: 46 year: 2008 end-page: 53 article-title: Metabolic adaptations through the PGC‐1α and SIRT1 pathways publication-title: FEBS Lett – volume: 434 start-page: 113 year: 2005 end-page: 118 article-title: Nutrient control of glucose homeostasis through a complex of PGC‐1α and SIRT1 publication-title: Nature – volume: 481 start-page: 463 year: 2012 end-page: 468 article-title: A PGC1‐α‐dependent myokine that drives brown‐fat‐like development of white fat and thermogenesis publication-title: Nature – volume: 30 start-page: 497 year: 2010 end-page: 506 article-title: Protein ‐glycosylation, protein folding, and protein quality control publication-title: Mol Cells – volume: 106 start-page: 1720 year: 2009b end-page: 1729 article-title: Resistance exercise with whey protein ingestion affects mTOR signaling pathway and myostatin in men publication-title: J Appl Physiol – volume: 37 start-page: 297 year: 2009a end-page: 308 article-title: Acute and long‐term effects of resistance exercise with or without protein ingestion on muscle hypertrophy and gene expression publication-title: Amino Acids – volume: 62 start-page: 1052 year: 2013 end-page: 1056 article-title: Elevated skeletal muscle irisin precursor FNDC5 mRNA in obese OLETF rats publication-title: Metabolism – volume: 488 start-page: E9 year: 2012 end-page: 10 article-title: Is irisin a human exercise gene publication-title: Nature – volume: 61 start-page: 1725 year: 2012 end-page: 1738 article-title: FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise publication-title: Metabolism – volume: 21 start-page: 402 year: 2010 end-page: 411 article-title: Effects of combined endurance and strength training on muscle strength, power and hypertrophy in 40–67‐year‐old men publication-title: Scand J Med Sci Sports – volume: 296 start-page: F459 year: 2009 end-page: F469 article-title: Role of ‐glycosylation in trafficking of apical membrane proteins in epithelia publication-title: Am J Physiol Renal Physiol – volume: 102 start-page: 205 year: 2008 end-page: 213 article-title: The effects of whey protein on myostatin and cell cycle‐related gene expression responses to a single heavy resistance exercise bout in trained older men publication-title: Eur J Appl Physiol – volume: 30 start-page: 879 year: 2009 end-page: 887 article-title: Strength [corrected], endurance or combined training elicit diverse skeletal muscle myosin heavy chain isoform proportion but unaltered androgen receptor concentration in older men publication-title: Int J Sports Med – volume: 98 start-page: E769 year: 2013 end-page: 778 article-title: Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance publication-title: J Clin Endocrinol Metab – volume: 9 start-page: 90 year: 2012 article-title: Greater insulin sensitivity in calorie restricted rats occurs with unaltered circulating levels of several important myokines and cytokines publication-title: Nutr Metab (Lond) – ident: e_1_2_6_2_1 doi: 10.1055/s-0029-1238290 – ident: e_1_2_6_5_1 doi: 10.1007/s00421-007-0579-4 – ident: e_1_2_6_11_1 doi: 10.1371/journal.pone.0060563 – ident: e_1_2_6_3_1 doi: 10.1038/nature10777 – ident: e_1_2_6_8_1 doi: 10.1111/j.1600-0838.2009.01059.x – ident: e_1_2_6_14_1 doi: 10.1007/s10059-010-0159-z – ident: e_1_2_6_9_1 doi: 10.1210/jc.2012-2749 – ident: e_1_2_6_16_1 doi: 10.1038/nature11364 – ident: e_1_2_6_7_1 doi: 10.1152/japplphysiol.00087.2009 – ident: e_1_2_6_10_1 doi: 10.1016/j.metabol.2013.02.002 – ident: e_1_2_6_12_1 doi: 10.1016/j.febslet.2007.11.034 – ident: e_1_2_6_13_1 doi: 10.1038/nature03354 – ident: e_1_2_6_17_1 doi: 10.1152/ajprenal.90340.2008 – ident: e_1_2_6_6_1 doi: 10.1007/s00726-008-0150-6 – ident: e_1_2_6_4_1 doi: 10.1016/j.metabol.2012.09.002 – ident: e_1_2_6_15_1 doi: 10.1186/1743-7075-9-90 – reference: 19299575 - J Appl Physiol (1985). 2009 May;106(5):1720-9 – reference: 18036349 - FEBS Lett. 2008 Jan 9;582(1):46-53 – reference: 20030775 - Scand J Med Sci Sports. 2011 Jun;21(3):402-11 – reference: 23018146 - Metabolism. 2012 Dec;61(12):1725-38 – reference: 17924133 - Eur J Appl Physiol. 2008 Jan;102(2):205-13 – reference: 23498898 - Metabolism. 2013 Aug;62(8):1052-6 – reference: 18661258 - Amino Acids. 2009 Jul;37(2):297-308 – reference: 23067400 - Nutr Metab (Lond). 2012 Oct 15;9(1):90 – reference: 22932392 - Nature. 2012 Aug 30;488(7413):E9-10; discussion E10-1 – reference: 24187077 - J Physiol. 2013 Nov 1;591(21):5267-8 – reference: 19885781 - Int J Sports Med. 2009 Dec;30(12):879-87 – reference: 23436919 - J Clin Endocrinol Metab. 2013 Apr;98(4):E769-78 – reference: 22237023 - Nature. 2012 Jan 26;481(7382):463-8 – reference: 15744310 - Nature. 2005 Mar 3;434(7029):113-8 – reference: 23593248 - PLoS One. 2013;8(4):e60563 – reference: 21340671 - Mol Cells. 2010 Dec;30(6):497-506 – reference: 18971212 - Am J Physiol Renal Physiol. 2009 Mar;296(3):F459-69 |
| SSID | ssj0013099 |
| Score | 2.5540109 |
| Snippet | Key points
•
Contradictory findings have been reported concerning the function of irisin and its precursor gene, skeletal muscle FNDC5, in energy homeostasis... Contradictory findings have been reported concerning the function of irisin and its precursor gene, skeletal muscle FNDC5 , in energy homeostasis and metabolic... Recently, contradictory findings have been reported concerning the function of irisin and its precursor gene, skeletal muscle FNDC5, in energy homeostasis, and... Key points * Contradictory findings have been reported concerning the function of irisin and its precursor gene, skeletal muscle FNDC5, in energy homeostasis... times Contradictory findings have been reported concerning the function of irisin and its precursor gene, skeletal muscle FNDC5, in energy homeostasis and... Recently, contradictory findings have been reported concerning the function of irisin and its precursor gene, skeletal muscle FNDC5 , in energy homeostasis,... |
| SourceID | pubmedcentral proquest pubmed crossref wiley |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 5393 |
| SubjectTerms | Adult Age Factors Aged Case-Control Studies Exercise Fibronectins - blood Fibronectins - genetics Fibronectins - metabolism Gene expression Homeostasis Humans Male Mens health Metabolism Middle age Middle Aged Muscle, Skeletal - metabolism Muscle, Skeletal - physiology Musculoskeletal system Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha Physical Endurance Physical fitness Resistance Training RNA, Messenger - genetics RNA, Messenger - metabolism Skeletal Muscle and Exercise Transcription Factors - genetics Transcription Factors - metabolism Transcription, Genetic |
| Title | Are skeletal muscle FNDC5 gene expression and irisin release regulated by exercise and related to health? |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1113%2Fjphysiol.2013.263707 https://www.ncbi.nlm.nih.gov/pubmed/24000180 https://www.proquest.com/docview/1447197992 https://www.proquest.com/docview/1449273536 https://www.proquest.com/docview/1468358684 https://pubmed.ncbi.nlm.nih.gov/PMC3936375 |
| Volume | 591 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3fb9MwED5Ne-IFGONHYCAjId5SZjux4ydUbZRpEtOENqlvUew4pRtz0NpKK389ZzsJlCFA8NJKyTmK3Tvfdz3fdwCvaNNkVUFtWmFknWZK07RSTKbCZjIraiNYqJD7cCKOzrPjaT7dgklfCxP5IYY_3LxlhP3aG3iluy4k1JMNXITQv_XpA8pHTHAZisopF55C__Aj-55M2FdqIA2XOe0q6PAxb371kE0PdQt23j49-SOqDW5pcg9m_YTiaZTL0WqpR-brT1yP_z_j-3C3Q65kHFVtB7asewC7Y4dR-9WavCancVg7W-_CfHxtyeISXRpie3K1WuAIMjk5PMgJKqwl9qY7f-tI5Woyx51m7ojv34JOFb9nvqmYrYlek74nVBAMlTd4fdmSWMD59iGcT96dHRylXVOH1PgMZKowQtGSVoJSjdhJaJrltsCNB3FFwxqLEanSQhguLdfMNrrQSmR5LbVUrGo0fwTbrnX2CRCzXwuT16Y2HoewolAGg32jacNYLa1MgPc_ZGk6xnPfeONzGSMfXvYrWvoVLeOKJpAOo75Exo8_yO_1OlJ29r_AgAqdvs-YsgReDrfRcn06pnK2XQUZtAqec_E7GYEQuRBFlsDjqHbDS_nTv55-LQG5oZCDgGcO37zj5p8CgzhXHN89T4AFffureZZnx6e-BeXTfxn0DO74q7GIcw-2l9cr-xzR3FK_CLaKn--n9BveY0aV |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3fb9MwED5N4wFe-DVggQFGQrylzHZix0-oGpQytmpCnbS3KHacrYwlaG0lyl_P2U4CZQgQ4qlSc45i5873Xc73HcBzWlVJkVEbFxhZx4nSNC4Uk7GwiUyy0gjmK-QOJ2J8nOyfpCcb8LarhQn8EP0HN2cZfr92Bu4-SLdW7tgGPvrYv3H5A8oHTHDpqsqv-VSdQ0cf2Pd0wq5SPW24TGlbQ4f3efmru6z7qCvA8-r5yR9xrXdMo1tw1k0pnEc5HywXemC-_sT2-B_mfBtutuCVDIO23YENW9-FrWGNgfvFirwgR2FYc7ragtnw0pL5OXo1hPfkYjnHEWQ0eb2XEtRZS-yX9ghuTYq6JDPcbGY1cS1c0K_i76nrK2ZLolekawvlBX3xDf6_aEio4Xx1D45Hb6Z747jt6xAbl4SMFQYpWtJCUKoRPglNk9RmuPcgtKhYZTEoVVoIw6XlmtlKZ1rhSy2llooVleb3YbNuarsNxOyWwqSlKY2DIizLlMF432haMVZKKyPg3ZvMTUt67npvfMpD8MPzbkVzt6J5WNEI4n7U50D68Qf5nU5J8nYLmGNMhX7fJU1ZBM_6y2i8LiNT1LZZehk0DJ5y8TsZgSg5E1kSwYOgd_1DuQPAjoEtArmmkb2AIw9fv1LPzjyJOFccnz2NgHmF-6t55tP9I9eF8uG_DHoK18fTw4P84N3k_SO44SRCTecObC4ul_YxgruFfuIN9xtwVEnC |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwED9NQ0K88DU-sg0wEuItZbYTO35C1UY1BlQV2qS9RbHjdGUsmdZWovz1nO0kUIYAwVOk5BzF7p3vdz3f7wBe0KpKiozauMDIOk6UpnGhmIyFTWSSlUYwXyH3YSwOT5Kj0_R0A0ZdLUzgh-j_cHOW4fdrZ-CXZdUauSMb-ORD_8alDygfMMGlKyq_kQj0mA4cfWTfswl7SvWs4TKlbQkdvufVr96y7qKu4c7rxyd_hLXeL43uwLSbUTiOcj5YLvTAfP2J7PH_p3wXbrfQlQyDrt2DDVvfh61hjWH7xYq8JJMwrJmutmA2vLJkfo4-DcE9uVjOcQQZjQ_2U4Iaa4n90h7ArUlRl2SGW82sJq6BC3pVvE5dVzFbEr0iXVMoL-hLb_D-oiGhgvP1AzgZvTneP4zbrg6xcSnIWGGIoiUtBKUawZPQNElthjsPAouKVRZDUqWFMFxarpmtdKaVSNJSaqlYUWn-EDbrpraPgZi9Upi0NKVxQIRlmTIY7RtNK8ZKaWUEvPshc9NSnrvOG5_zEPrwvFvR3K1oHlY0grgfdRkoP_4gv9vpSN5uAHOMqNDru5Qpi-B5_xhN1-Vjito2Sy-DZsFTLn4nIxAjZyJLIngU1K7_KHf81_GvRSDXFLIXcNTh60_q2ZmnEOeK47enETCvb381z_z4aOJ6UG7_y6BncHNyMMrfvx2_24FbTiAUdO7C5uJqaZ8gslvop95svwFfY0hx |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Are+skeletal+muscle+FNDC5+gene+expression+and+irisin+release+regulated+by+exercise+and+related+to+health%3F&rft.jtitle=The+Journal+of+physiology&rft.au=Pekkala%2C+Satu&rft.au=Wiklund%2C+Petri+K&rft.au=Hulmi%2C+Juha+J&rft.au=Ahtiainen%2C+Juha+P&rft.date=2013-11-01&rft.pub=Blackwell+Science+Inc&rft.issn=0022-3751&rft.eissn=1469-7793&rft.volume=591&rft.issue=Pt+21&rft.spage=5393&rft.epage=5400&rft_id=info:doi/10.1113%2Fjphysiol.2013.263707&rft_id=info%3Apmid%2F24000180&rft.externalDocID=PMC3936375 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-3751&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-3751&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-3751&client=summon |